Oral transmucosal fentanyl citrate (OTFC) for the treatment of breakthrough pain in cancer patients: a controlled dose titration study

Publisher Website
Google Scholar
Abstract
Oral transmucosal fentanyl citrate (OTFC) is a novel opioid formulation in which the potent synthetic μ-agonist fentanyl is embedded in a sweetened matrix that is dissolved in the mouth. It is undergoing investigation as a treatment for cancer-related breakthrough pain, a prevalent phenomeno